AMAGLUST30&4M30TAB

Amaglust 30mg/4mg tablets are an oral combination medication formulated to improve glycemic control in adults with type 2 diabetes mellitus. It combines two active blood glucose-lowering agents with complementary mechanisms of action: Pioglitazone, a thiazolidinedione that increases insulin sensitivity in peripheral tissues, and Glimepiride, a sulfonylurea that stimulates insulin secretion from pancreatic beta cells. This dual-action therapy helps manage blood sugar levels effectively when diet, exercise, and single-agent therapies do not provide adequate control.